Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

James E. Trosko

James E. Trosko

Michigan State University USA

Chris Beecher

Chris Beecher

NextGen Metabolomics, Inc USA

Krishna Dronamraju

Krishna Dronamraju

Foundation for Genetic Research & University of Paris France

Dong-Qing Wei

Dong-Qing Wei

Shanghai Jiaotong University China

Kazuhiro Ogata

Kazuhiro Ogata

Yokohama City University Graduate School of Medicine Japan

Irena Roterman-Konieczna

Irena Roterman-Konieczna

Jagiellonian University Poland

Carol Robinson

Carol Robinson

University of Oxford UK

Thomas Carell

Thomas Carell

Ludwig Maximilians Universitat Munchen Germany

CBRT 2018

About Conference

Conference Series is a renowned organization that organizes highly notable conferences throughout the globe. Currently we are bringing forth 34th International conference on Chemical Biology & Radiation Therapy” scheduled to be held during September 26-27, 2018 in Chicago, USAThe conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Chemical Biology & Radiation Therapy.

Conference Series Organizes 3000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access Journals which contain over 70000 eminent personalities as editorial board members as reputed scientists and 1200+ Symposiums & Workshops.

Why to attend???

With members from around the world focused on learning about Chemical Biology & Radiation Therapy; this is your best opportunity to reach the largest assemblage of participants from the Chemical Biology & Radiation Therapy community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new developments, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Chemical Biology & Radiation Therapy are hallmarks of this conference.

Target Audience:

  • Students, Scientists
  • Researchers
  • Faculty
  • Chemistry, Biology, Pharmacy & Medical Colleges
  • Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Software developing companies
  • Manufacturing, Medical Devices Companies
  • Data Management Companies

2018 Highlights:

  • 200+ Participation (70 Industry: 30 Academia)
  • 5+ Keynote Speakers
  • 50+ Plenary Speakers
  • 20+ Exhibitors
  • 14 Innovative Educational Sessions
  • 5+ Workshops
  • B2B Meetings

Sessions & Tracks

Track 1: Essentials of Chemical Biology

Track 2: Chemical Biology: Methods & Protocols

Track 3: Chemical Biology of Glycoproteins

Track 4: Organic & Inorganic Chemical Synthesis

Track 5: Mass Spectroscopy in Chemical Biology

Track 6: Chemical Biology: Enabling Drug Discovery

Track 7: Computational Tools for Chemical Biology

Track 8: Chemical Biology: Techniques & Applications

Track 9: Ubiquitination

Track 10: siRNA-A Tool in Chemical Biology

Track 11: Medicinal Chemistry, Pharmacology & Chemical Biology

Track 12: Labeling & Sensing in Chemical Biology

Track 13: Radiation Therapy Clinical Applications

Track 14: Quality Management in Radiation Therapy

Track 15: The Physics of Radiation Therapy

Track 16: External Radiation Therapy

Track 17: Internal Radiation Therapy

Track 18: Novel Treatments in Radiation Therapy

Track 19: Protocols in Radiotherapy

Track 20: Radiopharmaceuticals

Track 21: Radioactive Waste Management

Track 22: Dosimetry & Treatment Planning

Track 23: Radio Biology in Radiation Therapy

Track 24: Health Care Systems & Human Resources in Radiation Therapy

Market Analysis

The global Chemical Biology market is projected to reach USD 13.60 Billion by 2022 from USD 6.52 Billion in 2017, at a CAGR of 15.8% during the forecast period. The growth of this market is majorly driven by factors such as increased research activities and R&D investments in the life science industry, rising number of genome projects, technological advancements in the life science & chemical industry, and rising incidence of infectious diseases & genetic disorders. The key players in the global Chemical Biology market are Thermo Fisher (US), Merck (Germany), Illumina (US), QIAGEN (Netherlands), New England Biolabs (US), Promega (US), Agilent (US), Roche (Switzerland), Takara Bio (Japan), Bio Basic (Canada), Jena Bioscience (Germany), and Molecular Biology Resources (US).

The report "Radiotherapy Market by Type (External (IGRT, IMRT, 3D-CRT), Internal (LDR, HDR) & Systemic), Product (Proton Beam, Cyberknife, LINAC, Seed, Samarium), Application (Prostate, Breast, Cervical), End User, and Region - Global Forecasts to 2022", The global radiotherapy market is projected to reach USD 9.47 Billion by 2022 from USD 6.81 Billion in 2017, at a CAGR of 6.8%. Technological advancements in radiotherapy systems, increasing incidence and prevalence of cancer, rising geriatric population, and growing adoption of radiotherapy devices and procedures are the major factors driving market growth.

No. of Participants per Country for Chemical Biology & Radiation Therapy Conferences


List of Societies & Associations for Chemical Biology and Radiation Therapy

  • American Association for Clinical Chemistry (AACC)
  • American Chemical Society
  • American Institute of Biological Sciences (AIBS)
  • Canadian Society for Chemical Technology
  • Chinese Chemical Society
  • Chemical Society of Japan
  • Indian Chemical Society
  • Italian Chemical Society
  • Danish Chemical Society
  • Société Chimique de France
  • Polish Chemical Society
  • Norwegian Chemical Society
  • The Korean Chemical Society
  • Royal Australian Chemical Institute
  • Royal Society of Chemistry
  • Swedish Chemical Society
  • American Board of Radiology
  • American Brachytherapy Society
  • British Institute of Radiology
  • Chinese Society of Radiology
  • Danish Society of Radiology
  • European Society of Radiology
  • Japan Radiological Society
  • International Society of Intraoperative Radiation Therapy
  • Korean Society of Radiology
  • Radiological Society of The Netherlands
  • Radiological Society of North America
  • Spanish Society of Radiology
  • Swiss Society of Radiology
  • Italian Society of Medical Radiology
  • Singapore Radiology Society
  • Turkish Radiological Society

Scope and Importance

Chemical biologists are uniquely positioned to contribute to malaria and tuberculosis research. By studying biological systems at the molecular level, researchers resolve mechanistic questions relating to disease biology. Chemical biologists, adept at creating cross-disciplinary tools, provide fresh insights into the drug discovery process, including target identification, lead candidate optimization and mechanistic studies of drug action. These same approaches may be used to control vectors, develop vaccines and engineer diagnostic systems. Although DNA-sequencing efforts have provided new windows on malaria and tuberculosis, chemical biology will be instrumental in translating this genetic information into the functional realm. Chemical biologists have rapidly developed methods to profile and analyze diverse proteins. Comparative proteomics using these tools will illuminate pathogen metabolism and may lead to the identification of unique targets for malaria and tuberculosis drug development.

Wider socioeconomic issues must be addressed to make diagnosis and treatment options more widely available to those in need. However, chemical biology, with its interdisciplinary focus, can offer the tools and insights necessary to tackle the important societal goal of improving global health.


Scope of Chemical Biology

Radiation therapy is a cancer treatment that uses concentrated radiation beams to kill cancer cells. The most common type of radiation therapy is external beam radiation. This type involves a machine that directs high-energy beams of radiation at cancer cells. The machine allows radiation to be targeted at specific sites, which is why doctors use external beam radiation for nearly all types of cancer. According to Clinical surveys, about half of all cancer patients will receive radiation therapy.

Radiation therapy is an important tool for treating cancer, and is often used in conjunction with other therapies, such as chemotherapy or tumor-removal surgery. The main goals of radiation therapy are shrinking tumors and kill cancer cells. While the therapy also will likely injure healthy cells, the damage isn’t permanent. Your normal, noncancerous cells have the ability to recover from radiation therapy. To minimize the effect radiation has on the body, the radiation is targeted only to a specific point(s) in your body.

Radiation therapy can be used during different stages of cancer treatment and for different outcomes. Radiation therapy can be used:

  • To alleviate symptoms in advanced, late-stage cancer
  • As the primary treatment for cancer
  •  In conjunction with other cancer treatments
  • To shrink a tumor before surgery
  • To kill any remaining cancer cells after surgery



Why Chicago, USA??

Chicago, officially the City of Chicago, is the third-most populous city in the United States. The Chicago metropolitan area, often referred to as Chicagoland, has nearly 10 million people and is the third-largest in the U.S. Chicago has often been called a global architecture capital. Chicago is considered one of the most important business centers in the world. Positioned along Lake Michigan, the city is an international hub for finance, commerce, industry, technology, telecommunications, and transportation: O'Hare International Airport is the second-busiest airport in the world when measured by aircraft traffic; the region also has the largest number of U.S. highways and railroad freight.

In 2016, Chicago hosted a record 54 million domestic and international visitors, making it one of the most visited cities in the United States. Landmarks in the city include Millennium Park, Navy Pier, the Magnificent Mile, Art Institute of Chicago, Museum Campus, the Willis (Sears) Tower, Museum of Science and Industry, and Lincoln Park Zoo. Chicago's culture includes the visual arts, novels, film, theater (especially improvisational comedy), and music, particularly jazz, blues, soul, hip-hop, gospel, and house music. There are many colleges and universities in the Chicago area; of which Northwestern University, the University of Chicago, and the University of Illinois at Chicago are classified as "highest research" doctoral universities. Chicago has professional sports teams in each of the major professional leagues. The city has many nicknames, the best-known being the Windy City and Chi-Town.

The most difficult decision to make regarding a vacation to Chicago is determining what to do and see among the region's vast and diverse offerings. Chicago County promises a truly remarkable vacation experience for everyone.

However, America commanded the largest share of the Chemical, Biological, Radiological market, followed by Europe. And Chicago, Illinois is one of the major hubs for companies, Institutes working on Chemical, Biological, Radiological and related fields.

Past Conference Report

Cancer Therapy 2017

The 25th World Congress on Cancer Science and Therapy 2017 was held at Baltimore during October 18-20, 2017.

The conference focused on Cancer Science and Therapy Medicine studies with the theme "Characterizing Novel Approaches in Diagnosis and Cancer Therapies". The meeting was engrossed in a rich diversified spectrum of comprehensive discussions on novel subjects like Cancer Therapy and Cancer Genetics, Cancer Cell Biology, Stem Cell Therapy, Immunotherapy, Cancer Biomarkers, Novel Approaches to Cancer Therapeutics, Childhood cancer and developmental stages, Cancer Management & Prevention, Targeted Cancer Therapy, Precision Medicine & Cancer Therapy, Cancer: Psychological & Social Aspects, Complementary and Alternative Cancer Treatment, Cancer Case Reports, Cellular and Technological Breakthroughs in Cancer, and Cancer Diagnostics & Diagnostic Market.

The conference embarked with the opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honourable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

  • Frédéric Baribaud, Johnson & Johnson, USA
  • Yoshiaki Omura, New York Medical College, USA
  • Diana Anderson, University of Bradford, UK
  • Jianhua Luo, University of Pittsburgh, USA
  • Michael Retsky, Harvard School of Public Health, USA
  • Sherry A Bradford, AccuTheranostics, USA
  • Xichun Sun, Virginia Commonwealth University, USA
  • Lowe Leroy, Lancaster University, UK
  • Melvin L DePamphilis, National Institute for Child Health & Human Development, USA
  • George Vasmatzise, Mayo Clinic, USA

Conference Series Ltd offers its heartfelt appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with Conference Series Ltd and supported the conference in every aspect, without which the conference would not have been possible.

Your reunion is our inspiration; keeping this motto in mind and having witnessed the triumph of Cancer Science and Therapy 2017, Conference Series Ltd would like to announce the commencement of the “26th Annual Congress on Cancer Science and Therapy” to be held during October 03-04, 2018 Los Angeles, USA. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness some invaluable scientific discussions and contribute to the future innovations in the field of Cancer Science and Therapy Research.

For More details: 


Past Reports  Gallery  

Nuclear Medicine 2016


The success of the Radiology conferences has given us the prospect to bring the gathering one more time. Conferenceseries LLC hosted the “International Conference on Nuclear Medicine & Radiation Therapy” during July 14-15, 2016 at Park Inn by Radisson Köln City West, Cologne, Germany. The conference was focused on Nuclear Medicine & Cancer Research studies with the theme “Fusion of Emerging Technologies: Nuclear Medicine & Radiation Therapy”. The meeting engrossed a vicinity of comprehensive discussions on novel subjects like radiology, medical imaging, radiation oncology, cancers, mammography, cancer detection.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

  • Dr. Carmen I Bigles, Coqui Pharma, USA
  • Dr. Pedro Serrano Ojeda, Carribean Cancer Center, USA
  • Dr. Marc Griffiths, University of West of Englad, UK
  • Dr. Timo Joensuu, Docrates Cancer Center, Finland
  • Dr. Michael Friebe, Otto von Gueriecke University, Germany
  • Dr. Joerg Traub, SurgicEye GmbH, Germany

Conferenceseries LLC offers its heartfelt appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with Conferenceseries LLC and supported the conference in every aspect, without which the conference would not have been possible.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Nuclear Medicine 2016, Conferenceseries LLC  would like to announce the commencement of the “2nd International Conference on Nuclear Medicine & Radiation Therapy” to be held during July 27-28, 2017 Rome, Italy. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Cancer Research.

Past Reports  Proceedings  Gallery  

Integrative Biology 2015

rd International Conference on Integrative Biology was held during August 04-06, 2015 at Melia Valencia, Valencia, Spain. The conference was marked with the attendance of Editorial Board Members of supported OMICS Group Journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference fruitful and productive.

This conference was based on the theme “Discovering, Innovating and Engineering Future Science” which included the following scientific tracks:  

  • Genomics and Bioinformatics
  • Integrative Computational Biology
  • Drug Discovery and Integrative Biology  
  • Cell Biology  
  • Tissue Biology
  • Developmental Biology
  • Bio-Engineering
  • Systems Toxicology
  • Ecology and Evolution
  • Systems Biology

Integrative Biology-2015 was moderated by Dr. Jacqueline M. Dresch (Clark University, USA) on the first and second day and by Dr. Andreia Antoniolli (Federal University of Mato Grosso do Sul, Brazil) on the third day.

We are thankful to our below Honourable guests for their generous support and suggestions.

  • Emmanuel Mic. Drakakis- Imperial College London, UK
  • Peter L. Nagy– Columbia University, USA
  • Armando del Rio Hernandez - Imperial College London, UK
  • Dang Duong Bang- Technical University of Denmark, Denmark
  • Mahmoud Rouabhia- Laval University, Canada

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following topics were highlighted as Keynote-presentations:

  • Ultra low power cytomimetic VLSI circuits: Synthesis method & proof-of-concept results: Emmanuel Mic. Drakakis - Imperial College London, UK
  • Integration of next-generation sequencing data with analytical chemistry, structural biology and cell biologyPeter L. Nagy – Columbia University, USA 

Various sessions were chaired and co chaired by: Jeffrey Zheng, Yunnan University, China, Anja Nohe, University of Delaware, USA, Robert A. Drewell, Clark University, USA, Armando del Rio Hernandez, Imperial College London, UK, Mahmoud Rouabhia, Laval University, Canada and Dang Duong Bang, Technical University of Denmark, Denmark, Nirmal K Shetty, Shri Krishna Research Centre, India, Jacqueline M. Dresch, Clark University, USA, Witold Chmielewski, Laval University, Canada.

OMICS Group has taken the privilege of felicitating Integrative Biology-2015 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event.

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Integrative Biology-2015. We are glad to inform that all accepted abstracts for the conference have been published in OMICS Group Journal of Biological Systems: Open Access as a special issue.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance. With the unique feedback from the conference, OMICS Group would like to announce the commencement of the "4th International Conference on Integrative Biology" to be held during June 13-15, 2016 at Berlin, Germany.


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date September 26-27, 2018

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Chemical Biology & Pharmaceutical Chemistry Biochemistry & Molecular Biology Journal Journal of Clinical Radiology and Case Reports Journal of Imaging and Interventional Radiology

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by